1. |
简钢仁, 郑若菲, 叶诚栋. 标准化作业程序在移动方舱医院全面快速展开的应用研究. 中华灾害救援医学, 2019, 7(10): 551-554.
|
2. |
王当瑞, 马友才, 王春香, 等. 武汉方舱医院问题分析及未来方舱建设思考. 建筑节能, 2021, 9(49): 166-170.
|
3. |
国家卫生健康委办公厅. 《新型冠状病毒肺炎诊疗方案》(试行第九版).2022-03-14.
|
4. |
刘俊峰, 翟晓辉, 向准, 等. 应对新型冠状病毒肺炎疫情的方舱医院建设管理探讨. 中国医院管理, 2020, 3(40): 12-14.
|
5. |
中国疾病预防控制中心. 新型冠状病毒肺炎应急响应机制流行病学组. 新型冠状病毒肺炎流行病学特征分析. 中华流行病学杂志, 2020, 41(2): 145-151.
|
6. |
Zhao YL, Nan YD, Jin FG. Role of angiotensin-converting enzyme (ACE) and ACE2 in a rat model of smoke inhalation induced acute respiratory distress syndrome. Burns, 2015, 41(7): 1468-1477.
|
7. |
Pinto BG, Oliveira AE, Singh Y, et al. ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19. J Infect Dis, 2020, 222(4): 556-563.
|
8. |
Guisado-Vasco P, Valderas-Ortega S, MM Carralon-Gonzalez, et al. Clinical characteristics and outcomes among hospitalized adults withsevere COVID-19 admitted to a tertiary medical center and receivingantiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort). E Clinical Medicine, 2020, 28: 100591.
|
9. |
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus infected pneumonia in Wuhan, China. JAMA, 2020, 323(11): 1061-1069.
|
10. |
李殿明, 刘传苗, 刘佳慧, 等. 普通型向重型演变的新型冠状病毒肺炎病人的危险因素分析. 蚌埠医学院学报, 2020, 45(4): 21-424.
|
11. |
Cilloniz C, Polverino E, Ewig S, et al. Impact of age and comorbidity on cause and outcome in communityacquired pneumonia. Chest, 2013, 144(3): 999-1007.
|
12. |
王阳春, 仝瑞祥, 刘飞, 等. 糖尿病患者易感新型冠状病毒的免疫因素分析. 中国糖尿病杂志, 2020, 28(3): 176-179.
|
13. |
赵茜, 曹相原, 刘伶俐, 等. 新型冠状病毒肺炎合并糖尿病患者精细化管理效果分析. 现代医院, 2020, 20(12): 1841-1844.
|
14. |
戴志辉, 高立冬, 罗垲炜, 等. 湖南省新型冠状病毒肺炎临床特征分析. 实用预防医学, 2020, 4(27): 396-399.
|
15. |
潘月影, 王玉锦, 祝婷婷, 等. 938 例老年新型冠状病毒肺炎患者 影像学表现. 放射学实践, 2020, 35(3): 269-271.
|
16. |
Halfmann PJ, Iida S, Maemura T, et al. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. Nature, 2022, 603(7902): 687-692.
|
17. |
Suzuki R, Yamasoba D, Kimura I, et al. Attenuated replication and pathogenicity of SARS-CoV-2 B. 1. 1. 529 Omicron. Nature, 2022, 603(7902): 693-699.
|
18. |
刘昌孝, 伊秀林, 崔涛, 等. 新型冠状病毒疫苗研发与评价. 药物评价研究, 2020, 43(7): 1421-1432.
|
19. |
Wang J, Jing R, Lai X, et al. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines, 2020, 8(3): 378-342.
|
20. |
赵春艳, 石晶, 张国峰, 等. 北京通州区中小学生家长为子女接种新冠疫苗意愿及影响因素. 中国学校卫生, 2021, 3(42): 371-380.
|